Skip to content
HowShorted

bluebird bio, Inc. short interest in 2023

In 2023, bluebird bio, Inc.'s disclosed short interest ran from 22.26% of shares outstanding on 13 Jan 2023 to 22.04% on 29 Dec 2023, a change of -0.22 percentage points. The year's high was 30.37% on 30 Jun 2023 and its low 19.99% on 30 Nov 2023, averaging 23.59% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.06 days on 30 Jun 2023. Full history: bluebird bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for bluebird bio, Inc. in 2023

2023 in figures

Start of year
22.26% (13 Jan 2023)
End of year
22.04% (29 Dec 2023)
Change
-0.22 pp
High
30.37% (30 Jun 2023)
Low
19.99% (30 Nov 2023)
Average
23.59%
Highest days to cover
9.06 (30 Jun 2023)
SEC filings marked
9

Every report in 2023

bluebird bio, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202322.26%5.34results (8-K)
31 Jan 202320.86%3.36
15 Feb 202320.90%6.27
28 Feb 202322.05%6.58
15 Mar 202324.74%4.72
31 Mar 202324.87%4.2210-K filed, results (8-K)
14 Apr 202322.32%4.63
28 Apr 202322.14%5.08
15 May 202322.08%5.6310-Q filed, results (8-K)
31 May 202323.26%6.74
15 Jun 202328.62%7.96
30 Jun 202330.37%9.06
14 Jul 202323.85%7.48
31 Jul 202327.11%4.39
15 Aug 202324.73%5.5510-Q filed, results (8-K)
31 Aug 202324.35%8.12
15 Sep 202327.15%7.82
29 Sep 202322.54%8.40
13 Oct 202323.06%7.47
31 Oct 202322.97%7.43
15 Nov 202320.57%5.1910-Q filed, results (8-K)
30 Nov 202319.99%5.30
15 Dec 202323.30%1.68
29 Dec 202322.04%1.00

See also: bluebird bio, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.